Just how a big a deal is today’s announcement that the steroid anti-inflammatory drug Dexamethasone has been shown to be effective at lowering the death toll of Covid-19 patients?
At first sight, this is a modest breakthrough. The drug was shown to reduce the death rate among patients on ventilators by a third and among those on oxygen by a fifth.
Already a subscriber? Log in
Get 10 issues
for $10
Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $10.
- Delivery of the weekly magazine
- Unlimited access to spectator.com.au and app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in